Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Fanfeng Bu

Fanfeng Bu publishes mostly in Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Glioma Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging and Cancer Genomics and Diagnostics.

ORCID 0000-0003-4595-402X OpenAlex
World rank
#3,447,149
of 7,710,434 ranked researchers
Rank in China
#540,865
of 978,568
Works
51
Citations
254
Citations per work
5.0
h-index
4
i10-index 3Top 94% in Cancer Research
Fanfeng Bu

What does Fanfeng Bu research?

Fanfeng Bu's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (28%).

Health Sciences: 22 works · 42.5% of their workMedicine: 22 works · 42.5% of their workPulmonary and Respiratory Medicine: 7 works · 14.4% of their workOncology: 6 works · 11.4% of their workGenetics: 5 works · 9.1% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 7.6% of their workEverything else: 15 works · 29.4% of their workLife Sciences: 14 works · 28.1% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 28.1% of their workCancer Research: 8 works · 15.2% of their workMolecular Biology: 7 works · 12.9% of their workTHEIR WORKFanfeng Bu51works
Life Sciences28%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2242.5%
  2. Everything else1529.4%
    1. Biochemistry, Genetics and Molecular Biology1428.1%
  1. 1Cancer Research15% of their works
  2. 2Pulmonary and Respiratory Medicine14% of their works
  3. 3Molecular Biology13% of their works
  4. 4Oncology11% of their works
  5. 5Genetics9% of their works
  6. 6Radiology, Nuclear Medicine and Imaging8% of their works

Research topics

Which keywords describe Fanfeng Bu's research?

The keywords of their largest research topics: Targeted Therapy, Precision Medicine, Tumor Microenvironment, Glioblastoma, Temozolomide, Medical Imaging, Radiomics and ALK Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy182 topics
  2. Precision Medicine172 topics
  3. Tumor Microenvironment122 topics
  4. Glioblastoma111 topic
  5. Temozolomide111 topic
  6. Medical Imaging101 topic
  7. Radiomics101 topic
  8. ALK Inhibitors91 topic
  9. Cancer Genomics91 topic
  10. EGFR Mutations91 topic
  11. Mutational Signatures91 topic
  12. Cetuximab71 topic
  13. KRAS Mutations71 topic
  14. Cancer61 topic
  15. Ferroptosis61 topic
  16. HIF-161 topic
  17. Microsatellite Instability61 topic
  18. Molecular Characterization61 topic
  19. Warburg Effect61 topic

Where does Fanfeng Bu work?

Fanfeng Bu's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Fanfeng Bu have?

OpenAlex counts 51 works and 254 citations for Fanfeng Bu, an h-index of 4, ranking #3,447,149 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Fanfeng Bu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.